Emergent BioSolutions Reports Third Quarter and Nine Months 2017 Financial Results; Raises Calendar Year 2017 Guidance

Go back to Emergent BioSolutions Reports Third Quarter and Nine Months 2017 Financial Results; Raises Calendar Year 2017 Guidance
EMERGENT BIOSOLUTIONS, Inc. (NYSE: EBS) Delayed: 6.00 -0.21 (3.38%)
Previous Close $6.21    52 Week High $44.38 
Open $6.15    52 Week Low $24.47 
Day High $6.15    P/E 300.00 
Day Low $5.96    EPS $0.02 
Volume 702,798